Uehiro Research Div. for iPS Cell Ethics
Misao Fujita (Professor)
Misao Fujita MS, MPH, Ph.D.
Research targeting the clinical application of human iPS cells is finally reaching a decisive stage. To ensure that it progresses swiftly and soundly, the cooperation and understanding of society, and especially of the research subjects is necessary. The Fujita Group is committed to investigating issues around the Act on the Safety of Regenerative Medicine and cell-based interventions, the use of human iPS cells to create chimeric animals and germ cells, and related questions with reference to domestic and international ethical regulation and government policy, public attitudes, and current practice. Our aim is to identify and clarify the ethical, social, and legal issues with potential impact on the clinical application of iPS cells and to explore and propose solutions.